<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02050672</url>
  </required_header>
  <id_info>
    <org_study_id>MI_ICSI</org_study_id>
    <nct_id>NCT02050672</nct_id>
  </id_info>
  <brief_title>Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome: a Prospective, Randomized Sibling-oocyte Study</brief_title>
  <acronym>MI_ICSI</acronym>
  <official_title>Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome: a Prospective, Randomized Sibling-oocyte Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGUNCO Obstetrics and Gynecology Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TECNOLAB center for assisted reproductive technologies</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AGUNCO Obstetrics and Gynecology Centre</source>
  <brief_summary>
    <textblock>
      In the present trial, the investigators aim to evaluate whether semen myo-inositol (MI)
      treatment is able to improve IVF outcomes.

      In particular, retrieved oocytes will be randomly divided in two groups, one group will be
      inseminated with MI treated semen while the other will be inseminated with untreated semen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myo is synthesized from glucose-6-phosphate, it is a precursor of second messengers in the
      cell signaling pathways and it is involved in the regulation of intracellular calcium.

      Literature data have demonstrated the MI play a crucial role in reproduction, indeed, oocyte
      and spematozoa are nursed in a medium congaing hig MI concentration.

      Furthermore, it has been demonstrated that, in oligoasthenoteratozoospermic patients, in
      vitro incubation with 2 mg/ml of myo increase significantly the number of spermatozoa with
      high mitochondrial membrane potential (MMP). Moreover, it has been found that the in vitro
      fertilization rate is correlated with the percentage of high MMP spermatozoa.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fetilization rate</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Embryo quality</measure>
    <time_frame>Day 2 to Day 5</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Couple Sterility</condition>
  <arm_group>
    <arm_group_label>untreated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Semen was prepared with routinely used media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>myo-inositol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>routinely used semen preparation media have been enriched with myo-inositol 2mg/ml.
in particular the stock solution was prepared in order to add 15microliters per ml of medium</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Myo-inositol</intervention_name>
    <arm_group_label>myo-inositol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>untreated</intervention_name>
    <arm_group_label>untreated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  couple counselled for IVF

        Exclusion Criteria:

          -  cryopreserved sample
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>TECNOLAB</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrizia Rubino, PhD</last_name>
      <phone>0270103344</phone>
    </contact>
    <investigator>
      <last_name>Patrizia Rubino, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012 Jun;79(6):1290-5. doi: 10.1016/j.urology.2012.03.005.</citation>
    <PMID>22656408</PMID>
  </reference>
  <reference>
    <citation>Nomikos M, Swann K, Lai FA. Starting a new life: sperm PLC-zeta mobilizes the Ca2+ signal that induces egg activation and embryo development: an essential phospholipase C with implications for male infertility. Bioessays. 2012 Feb;34(2):126-34. doi: 10.1002/bies.201100127. Epub 2011 Nov 16. Review.</citation>
    <PMID>22086556</PMID>
  </reference>
  <reference>
    <citation>Condorelli RA, La Vignera S, Di Bari F, Unfer V, Calogero AE. Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci. 2011 Feb;15(2):129-34.</citation>
    <PMID>21434479</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>January 29, 2014</last_update_submitted>
  <last_update_submitted_qc>January 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myoinositol</keyword>
  <keyword>ART</keyword>
  <keyword>EMBRYO QUALITY</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inositol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

